COLUMBUS, Ga., Nov 12, 2024 – Aspirion, a leader in healthcare technology revenue cycle management (“RCM”) for handling denials, payment variance, and complex claims, has appointed Nick Giannasi as its new Chief Executive Officer, effective immediately. Giannasi, renowned for his innovation in healthcare, RCM, and artificial intelligence (“AI”), is poised to drive Aspirion’s mission of advancing provider and patient outcomes through AI and technology. As hospitals and health systems grapple with financial challenges from increasing claim denials, Aspirion remains at the forefront, empowering providers with cutting-edge technology to secure proper reimbursement at scale.
Under Giannasi’s leadership, Aspirion is set to strengthen its role as a pioneer in AI-driven healthcare solutions, making healthcare more accessible and cost-effective. Amy Amick, who served as CEO and led significant advancements in Aspirion’s scale and maturity, will transition to the Board of Directors.
“I am thrilled to join Aspirion at an exciting time in the company’s history and trajectory and at a time of such need for our providers,” said Nick Giannasi, Chief Executive Officer, Aspirion. “Aspirion’s mission of getting providers paid fully, quickly, and transparently for their work deeply resonates with me and ultimately will make healthcare more affordable and accessible. Our approach fuses human expertise, artificial intelligence, and technology to streamline the claims process and reduce denials at exponential scale, delivering significant value to our provider clients and ensuring they can focus on what matters most—delivering exceptional patient care and supporting their communities.”
An Aspirion Board member since 2022, Giannasi has an impressive background in healthcare technology, holding patents in AI and technology innovations. His previous roles span leadership positions at Ciox (Chief Product Officer), Datavant (Head of Demand Side Product), Change Healthcare (Executive Vice President, Chief AI Officer, and Chief Data Officer), and Oracle (Vice President of Life Sciences Product Strategy). He also has entrepreneurial experience as a co-founder of Phenocure LTD, a biotech firm.
“Nick embodies the requisite strategic vision to guide Aspirion forward in this rapidly evolving payor-provider landscape,” stated Aspirion’s Board of Directors. “His proven success in merging clinical expertise with AI and technology positions him uniquely to address the RCM industry’s evolving demands. His experience will drive Aspirion’s mission to enhance operational efficiency while advancing patient access and quality of care. We are grateful for the leadership Amy brought to Aspirion, positioning the company for continued success and value creation moving forward.”
About Aspirion
Founded in 2006, Aspirion specializes in revenue cycle management (RCM) for complex claims and denials. Known as a trusted partner to providers, Aspirion manages claims such as Motor Vehicle Accident (MVA), Third-party Liability (TPL), Workers’ Compensation, Veterans Administration, and Out-of-State Medicaid, as well as Denials Management, Underpayments Recovery, and Aged Accounts Receivable (AR). Aspirion’s skilled team of investigators, specialists, clinicians, coders, and attorneys work to secure maximum reimbursements, supporting clients in delivering better healthcare outcomes.
Click Here to Join HR TODAY WhatsApp Channel
Read Also : Cultivating Safe Spaces: The Strategic Role of L&D in Workplace Well-being
